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Using polyclonal rabbit antibodies against bovine FKBP25, NEPHGE/SDS-PAGE and Western blotting we demonstrate that the rapamycin- 
specific immunophilin FKBP25 is present in T-lymphoma Jurkat cells. Subsequent fractionations of the soluble Jurkat cell proteins have revealed 
that FKBP25 predominantly occurs in the nuclear fraction. FKBP25 has the ability to bind to DNA. The FKBP2YDNA complex can be dissociated 
in the presence of a high salt concentration. FKBPl2, which shares high amino acid sequence homology to the C-terminal domain of FKBP25, 
has no tendency to bind to DNA. CD-constrained predictions of the secondary structures in FKBP25 suggest hat an amphipathic helix-loophelix 
occurs in the N-terminal part of the protein and may account for its Minding to DNA. 
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1. INTRODUCTION 
Immunophilins form a subgroup of peptidyl-prolyl 
cis-tram isomerases (PPIases) which catalyze the inter- 
conversion of cis- and tram- rotamers of the peptidyl- 
prolyl amide bond of peptide and protein substrates [ 11. 
They also bind the immunosuppressive drugs FK506 
[l-3], rapamycin [24] and cyclosporin A [5]. At present 
27 different amino acid sequences of cyclophilins, re- 
ferred to as the cyclosporin-A binding proteins and 17 
different sequences of FKBPs known as the FK506 or 
rapamycin binding proteins, have been deposited to the 
MIPSX protein data-bank. However, only few im- 
munophilins have been isolated from organs and cell 
lines and partially characterized [l-7]. Cyclophilin was 
the first PPIase whose isolation from porcine kidney 
cortex and bovine thymocytes was described [8,9]. Sub- 
sequently FKBP12 was isolated from bovine thy- 
mocytes and human spleen [2] and T-lymphoma Jurkat 
cells [3]. Various cellular targets for the complexes of 
cyclophilin with CsA, and FKBP12 with FK506 or ra- 
pamycin were identified and correlated with the im- 
munosuppressive actions exerted by the drugs [6,7,10]. 
However, no molecular targets for FKBP25 [4] have yet 
been identified. 
and to examine the possiblity that the protein is located 
in the nucleus of T-cells. In this paper we report on the 
localization of FKBP25 in T-lymphoma Jurkat cells 
and on its ability to bind to DNA under in vitro condi- 
tions. 
2. MATERIALS AND METHODS 
2.1. Tissue source. chemicals and chromatography materials 
Calf brain was supplied fresh on ice by the Henri Meunier slaughter 
house (Meaux, 77. France). The fresh tissue was shredded and frozen 
in liquid nitrogen. SDS-PAGE and NEPHGE chemicals were pur- 
chased from Serva and Pharmacia/LKB. All other chemicals were of 
analytical grade and purchased from either Bio-Rad or Sigma. 
2.2. NEPHGE and SDS-PAGE electrophoresis 
NEPHGE was performed in glass tubes (18 cm x 2.4 mm). Mixtures 
of proteins were treated with the lysis buffer (9.8 M urea, 2% w/v 
NP-40,2% carrier ampholytes and 100 mM DTT) and loaded imme- 
diately onto the tubes. NEPHGE was carried out for 4 h at a constant 
voltage of 400 V. The following protein markers were used to establish 
an approximate pI scale: FKBPl2 from bovine thymus, two isoforms 
of cyclophilin from bovine spleen, FKBP25 from bovine brain, two 
isoforms of aspartate aminotransferase from bovine brain and cyclo- 
philin from E. COIL The gels were excised from the tubes, soaked in 
SDS-PAGE buffer for 15 min and reloaded onto a 12% SDS-PAGE 
(20 cm x 20 cm) - Protean II apparatus (Bio-Rad). Proteins were 
visualized by either silver staining [1 1] or immunostaining. 
Analyses of the amino acid sequence of FKBP25 re- 
vealed putative nuclear translocation signals [4]. More- 
over, the primary extraction of FKBP25 [4] from bovine 
organs required a high concentration of salt [4]. These 
properties prompted us to further investigate FKBP25 
2.3. Preparation of FKBPZS antibodies 
FKBP25 was isolated as recently described [4] with a small modifi- 
cation, namely preparative IEF was replaced by chromatofocusing on 
PBE118. Male de Bouscat White rabbits were injected subscapulary 
with approximately 100 mg of protein in complete Freund’s adjuvant. 
It was followed by two other injections with incomplete Freund’s 
adjuvant. Antibody titers were monitored by immunoblotting with 
purified bovine FKBP25. 
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2.4. Cell culture and cell fractionation 
Jurkat cells (lo*) were grown in a RPM1 1640 medium supple- 
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mented with 10% fetal calf serum, L-glutamine (2 mM), HEPES (10 
mM), gentamycine 100 mg/ml, sodium pyruvate (2 mM) at 37’C in 
a humidified 7% carbon dioxide atmosphere. The cells were harvested 
by cent~fugation at 300 x g and washed twice with PBS (10 mM 
phosphate, pH 7.4, 3 mM KCl, 150 mM N&l). The cells were frac- 
tionated for cytosolic and nuclear fractions according to the procedure 
of Challberg and Kelly [12]. Briefly, the cells were washed once in cold 
hypotonic buffer (20 mM HEPES pH 7.5,5 mM KCl, 0.5 mM M&l,, 
0.5 mM DTT and 0.2 M sucrose), resuspended in 1 ml ofthe hypotonic 
buffer without sucrose and let to swell for 10 min on ice. The cells were 
lysed by passing the mixture through a 25-G needle. The mixture was 
centrifuged for 5 min at 2000 x g. The resulting supernatant was ten- 
trifuged at 15 000 x g for 20 min which yielded clear cytoplasmic 
fraction. The nuclear pellet was resuspended in 500 ml of 50 mM 
HEPES pH 7.5, 10% sucrose, frozen in liquid nitrogen and thawed. 
After addition of NaCl to reach 100 mM salt concentration the sus- 
pension was incubated 1 h on ice and then centrifuged at 15 000 x g 
for 20 min. The su~rnatant which contained soluble nuclear proteins 
was concentrated. Each fraction was mixed with the NEPHGE lysis 
buffer and subjected to NEPHGE. Protein concentrations were esti- 
mated using the Bradford reagent (Bio-Rad). 
2.5. Western blotting 
Samples (ca. 40 mg of Jurkat proteins) isolated by fractionation of 
10” cells were successively subjected to NEPHGE and SDS-PAGE 
electrophoresis (2D). Proteins from SDS-PAGE gels were electro- 
transferred (400 mA for 2 h) to nitrocellulose membranes (Bio-Rad) 
in 25 mM Tris pH 8.35, 192 mM glycine and 10% methanol. Mem- 
branes were regenerated in PBS, 1% Triton X-100, for 0.5 h, blocked 
for 1 h with a solution of 1% bovine serum albumin and 1% bovine 
caseine in PBS and incubated overnight with a 11500 dilution of anti- 
FKBP25 antiserum in the blocking buffer. Normal rabbit serum was 
used as a negative control. The membranes were incubated for 1 h with 
biotinylated monoclonal anti-rabbit Ig (Sigma) diluted 115000 which 
was followed by incubation with a streptavidine-peroxidase complex 
0.1 units/ml (Sigma). lmmunoreactive bands were visualized with 
0.04% DAB (Sigma), 0.3 mg/ml CoClz (Sigma) and H,Oz (30%) 1 
ml/ml in PBS. Between each step the membranes were washed (4 x 5 
min) with PBS/Tween 20 (0.05%) buffer. 
2.6. FKBP2Sl[ealf thymus-DNA j complexes 
50 mg of a double-stranded calf thymus-DNA-cellulose affinity 
matrix (4 mg of double-stranded DNA per 1 g of solid phase, Sigma 
-lot 10187165) was mixed with 1 ml of20 mM HEPES pH 7.3,2 mM 
MgCl,. 1 mM CaCl,, 1 mM EDTA, 0.5% Triton X-100 (binding 
buffer) and let to swell for 24 h. A series of the complexes FKBP251 
DNA-affinity matrix was prepared by mixing 75 ml of DNA-a~nity 
matrix suspension in the binding buffer which contained 0.204 mg of 
the double-stranded DNA from calf thymus per 1 ml with 3.3 mg of 
bovine FKBP25. DNA-affinity matrices were sparingly vortexed and 
let to equilibrate for at least 3 h and aliquots with unbound FKBP25 
were collected by centrifugation. Each DNA-affinity matrix was 
washed three times by vigorous vortexing in the buffer. The retained 
FKBP25 on DNA-a~nity matrix was eluted with an increasing con- 
centration of NaCl in the binding buffer as given in the caption to Fig. 
2. The salt-eluted FKBP25 was precipitated with an equal volume of 
20% trichloroacetic acid, treated with SDS lysis buffer and loaded on 
12% SDS-PAGE gels. Similar steps were performed for binding of 
bovine FKBP12 to the same amount of DNA-affinity matrix as above. 
2.7. CD spectroscopy and u~o~yses of protein sequences and protein 
database 
Circular dichroism spectra of FKBP25 and a mixture of FKBP25 
with a double-stranded DNA from calf thymus (27 kb, Sigma) were 
recorded with a Jobin Yvon Mark VI dichrometer. The CD spectra 
were measured at room temperature in20 mM HEPES, pH 7.2, 1 mM 
EDTA. The secondary structure of FKBP25 was predicted with the 
SEQPRO program using the CD-constrained procedure [4]. The pre- 
dicted a-helical segments were analysed for potential ~phipathl~ 
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character using the Fourier transform procedure [13]. The hydropho- 
bicity index (H,) was calculated as a ratio of the amino acid residues 
being in the hydrophobic segments to their total. The hydrophobic 
segments were calculated with SEQPRO using a nine-residue window 
and the Kyte-Doolittle hydrophobicity scale [14J. The current edition 
of the MIPSX protein data base (release 33 with 61811 sequences) was 
searched with SEQPRO. 
3. RESULTS 
Soluble proteins from the nuclear and cytosolic com- 
partments of T-lymphoma Jurkat cells were separated 
from each other. Subsequently, they were subjected to 
NEPHGEISDS-PAGE and Western blotting. Only one 
protein of the nuclear fraction cross-reacted with a rab- 
bit antisera raised against bovine FKBP25 (see Fig. 
1A). The coordinates of this immunospot are identical 
to those of bovine FKBP25 on a 2D map of the stand- 
ard proteins (see Fig. 1B and section 2). Control exper- 
iments revealed that no protein was immunostained 
using a normal rabbit serum. The presence of FKBP25 
in the nuclear fraction of T-lympho~ Jurkat cells was 
thus firmly established. However, a proportion of 
FKBP25 was also found in the cytosolic fraction (data 
not shown). 
In the presence of a low salt concentration FKBP25 
was retained on DNA covalently bound to cellulose. 
The protein was gradually released from the affinity 
matrices with an increasing concentration of NaCl (see 
Fig. 2). In contrast, FKBP12 was not retained by DNA- 
affinity matrix (data not shown). 
4. DISCUSSION 
Our experiments revealed that FKBP25 is present in 
the nucleus of T-lymphoma Jurkat cells. This observa- 
tion is in agreement with the previous proposal [4] that 
the amino acid sequence of FKBP25 contains nuclear 
translocation signals. A proportion of FKBP25 was 
found, however, in the cytosolic fraction which might 
be due to its extraction from the nucleus during cell 
fractionation under hypotonic conditions, like in the 
case of the Ets-1 transcription factors and retinoblas- 
toma [ 15,161. Alternatively it might come from an asso- 
ciation of FKBP25 with a cytosolic component. 
At a low salt concentration FKBP25 was retained on 
DNA-affinity matrices. The range of NaCl concentra- 
tion which was needed to elute FKBP25 from DNA- 
affinity matrices suggests that the protein has the ability 
to bind to DNA. Similar concentrations of NaCl were 
required for the initial extraction of FKBP25 from var- 
ious animal organs 141. Likewise high salt concentration 
is frequently used to isolate various DNA-binding pro- 
teins [I 71. Hence, the ability of FKBP25 to bind to DNA 
is compatible with its nuclear localization. 
Association between FKBP25 and DNA could be 
rationalized in terms of structural elements present in 
the former. The secondary structures of FKBP25 pre- 
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Fig. 1. (A) A specifically immunostained Western blot of nuclear proteins from the T-lymphoma Jurkat cells. Non-immune rabbit serum was used 
as a negative control. The positions of prestained molecular weight markers are indicated on the side of the gel (Bio-Rad). (B) NEPHGE/SDS-PAGE 
of the protein markers which are described in section 2: 1, FKBP12; 2, bovine cyclophilin; 3, E. co/i cyclophilin; 4, FKBP25; 5. two rsoforms of 
aspartate aminotransferase. The positions of molecular weight markers (Bio-Rad) and approximate pI scale are indicated on the sides of the gel. 
dieted with the CD-constrained algorithm have revealed 
(see Fig. 3) that the protein could be divided into two 
domains [4]. The N-terminal domain (1 to 104) was 
predicted to comprise a number of a-helical segments, 
whereas the C-terminal domain (from 122 to 223) 
should have a chain fold similar to that of FKBP12 
[l&19]. The predicted a-helices (7-19) and (33-50) are 
connected to each other by an extended loop-p-turn 
segment (21-32) and form an amphipathic helix-loop- 
helix (HLH). This characteristic DNA binding motif 
[20] occurs in the sequences of various transcription 
factors [21] and other DNA-binding proteins [20]. Fur- 
thermore, FKBP25 is a very hydrophilic protein 
(H, = 17.9% for FKBP25, Hi = 0% for histones whereas 
it is over 60% for membrane-associated proteins) and 
contains a number of Lys residues which may further 
stabilize the FKBP25/DNA complex. However, the CD 
spectra of a mixture of FKBP25 and double-stranded 
DNA have shown no significant change in protein con- 
formation. Thus if the putative HLH motif exists in the 
N-terminal part of FKBP25 its binding to DNA is not 
accompanied by any significant change of the secondary 
structures of the immunophilin. However, the complex 
also could be due to chargecharge interaction between 
DNA and the multiple repeats of K and R residues 
separated by six or seven residues (see Fig. 3). The latter 
could also be aided by such elements as the NTS specific 
-KKKKNAK- sequence. 
Different targets for FKBP12 and cyclophilin bound 
to their respective ligands have been identified [6,7,10]. 
These findings have led to several models accounting 
for the immunosuppressive actions exerted on T-cells by 
CsA, FK506 and rapamycin [6,7]. 
FK506 and CsA act early on T-cell activation cascade 
and stop the antigen induced transcription of the IL2 
gene [6,7]. The drugs block cell transition from G, to G, 
while they do not arrest cell proliferation. In contrast, 
rapamycin acts later in the T-cell activation cycle and 
arrests an ILZreceptor initiated T-cell progression from 
G, to the S phase. The latter process involves a large 
number of gene products essential for the cell division 
cycle. It has been established that FKBP25 has a higher 
affinity for rapamycin than for FK506 [4], yet the rea- 
son for this difference remains unclear. It could be of 
interest to explore the possibility of a linkage between 
highly specific binding of rapamycin to FKBP25 [4], the 
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Fig. 2. (A) Lanes 1-7 show FKBP25 that was eluted from 7 DNA-affinity matrices after their treatment with the following concentrations of NaCI: 
I (500 mM), 2 (300 mM). 3 (250 mM), 4 (200 mM), 5 (I 50 mM), 6 (100 mM), 7 (50 mM). (B) FKBP25 retained on the respective 7 DNA-affinity 
matrices after their treatment with NaCI. 
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Fig. 3. CD-constrained prediction of the secondary structures (C-pred) in human FKBPZS [22]. Since the C-terminal part of FKBP25 shares 
considerable sequence homology to FKBPl2 the X-ray assignment of its secondary structure (X-ray) is also given [19] ; z, B-turn; a, a-helix; /?. 
/?-structure: t) an extension of the structure. 
ability of FKBP25 to bind to DNA, and the action of 
rapamycin on the cell division process. 
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